Biocartis Group N.V.

BIOGF · OTC
Analyze with AI
6/30/2023
12/31/2022
6/30/2022
12/31/2021
Operating Activities
Net Income-$31-$37-$65,344-$35,736
Dep. & Amort.$5$5$10,476$4,923
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$640$380
Change in WC-$3-$3-$3,854-$4,824
Other Non-Cash-$1$14$17,598$4,125
Operating Cash Flow-$29-$21-$44,834-$32,858
Investing Activities
PP&E Inv.-$0-$1-$1,936-$1,878
Net Acquisitions$0$0-$1,000$0
Inv. Purchases$0$0-$2,500$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1-$3-$1-$0
Investing Cash Flow-$1-$4-$5,427-$1,874
Financing Activities
Debt Repay.$0$0-$519-$545
Stock Issued$0$0$23,055$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$30$32-$105-$58
Financing Cash Flow$30$32$22,431-$602
Forex Effect-$0-$1$427$261
Net Chg. in Cash-$0$3-$53,522-$70,146
Supplemental Information
Beg. Cash$0$0$53,522$123,668
End Cash-$0$3$0$53,522
Free Cash Flow-$29-$22-$46,770-$34,736